The Global Leukodystrophy Initiative - Clinical Trials Network (GLIA-CTN)

We are excited to say that Global DARE Foundation​ is now a Patient Advocacy partner with the Global Leukodystrophy Initiative​. Our voice will be heard as they shape this great initiative now and into the future!

"The Global Leukodystrophy Initiative Clinical Trials Network (GLIA-CTN) is a consortium of scientists, industry stakeholders, and patient advocacy leaders working together to promote advances in the diagnosis and treatment of leukodystrophies. Specifically, it seeks to create a robust research infrastructure that will allow for collection and analysis of longitudinal natural history data, development of novel clinical outcome assessments, and identification of surrogate biomarkers – ultimately paving the way for transformative therapeutic trials across the leukodystrophies".

You can find out more by visiting their new website at http://theglia.org/

Contact us

P.O.Box 865

Windham, Maine 04062

United States

info@GlobalDAREFoundation.org

Follow us

  • Facebook
  • LinkedIn Social Icon

EIN: 84-3343395

501(c)(3) IRS Approval:

Disclaimer:
This website is not designed to diagnose, advise or provide medical opinions, treatment or services. It is for general knowledge purposes only. Please consult a licensed medical professional with all questions and concerns regarding a medical condition. 

© 2020 Global DARE Foundation